 Product Service News
September 17, 2024
In the present age of rapid technological advancement, wherein clandestine endeavors are adeptly masked beneath layers of digital obfuscation, it becomes paramount for the guardians of law and order to possess the most sophisticated tools at their disposal. In an illustrious development that bespeaks the continuing ...
|
Clinical Study
September 17, 2024
Forging New Frontiers in Cancer Therapy: NextCure Unveils Promising Phase 1b Study Results at ESMO 2024 BELTSVILLE, Md. Sept. 16, 2024 In a stirring presentation, NextCure, Inc. (Nasdaq: NXTC) revealed groundbreaking clinical data at the European Society for Medical Oncology (ESMO) 2024 Congress. This clinical-s...
|
Clinical Study
September 17, 2024
In this esteemed publication, we take the liberty of presenting findings that emanated from a notable assembly, the European Society for Medical Oncology (ESMO) Congress of the year 2024, where Apollomics revealed significant data concerning Vebreltinib a novel therapeutic agent under examination for its utility i...
|
|
 Management Changes
September 16, 2024
Understanding Brown & Brown, Inc. s Recent Leadership Changes and Market Performance: A Dive into Financial Updates and Cultural Influences
On September 16, 2024, Brown & Brown, Inc. (NYSE: BRO), a prominent player in the insurance industry, announced a significant shift in its senior leadership team with the ap...
 Product Service News
September 17, 2024
Revolutionizing Mental Health Care: NeuroStar s Commitment to Patient-Centric Solutions In a groundbreaking advancement for mental health care, NeuroStar, a leader in transcranial magnetic stimulation (TMS) therapy, has recently announced a suite of software upgrades designed to enhance patient care across multiple ...
|
|
Our most Popular Articles
|
Announcement
March 30, 2025
In the fast-paced world of biotechnology, the importance of protecting investor interests cannot be overstated. As the landscape shifts with breakthrough research and corporate developments, the cautionary tales of missteps and missed opportunities proliferate. In this regard, Rosen Law Firm, a respected global inve...
|
Product Service News
October 16, 2024
Shining Through: Gatos Silver’s Stellar Q3 and Optimistic 2024 Outlook In the dynamic realm of the precious metals industry, Gatos Silver, Inc. a prominent figure in silver mining, recently unveiled their production results for the third quarter of 2024. In a world where economic fluctuations are constant and mark...
|
Product Service News
May 13, 2024
Utrecht, The Netherlands, and Cambridge, Mass. - Merus N.V. (Nasdaq: MRUS), a leading clinical-stage oncology company specializing in the development of innovative antibodies for cancer treatment, is thrilled to announce today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designat...
|
|
|
Company News
|
Clinical Study
September 17, 2024
Forging New Frontiers in Cancer Therapy: NextCure Unveils Promising Phase 1b Study Results at ESMO 2024 BELTSVILLE, Md. Sept. 16, 2024 In a stirring presentation, NextCure, Inc. (Nasdaq: NXTC) revealed groundbreaking clinical data at the European Society for Medical Oncology (ESMO) 2024 Congress. This clinical-s...
|
Clinical Study
September 17, 2024
In this esteemed publication, we take the liberty of presenting findings that emanated from a notable assembly, the European Society for Medical Oncology (ESMO) Congress of the year 2024, where Apollomics revealed significant data concerning Vebreltinib a novel therapeutic agent under examination for its utility i...
|
Clinical Study
September 17, 2024
BioAtla Demonstrates Promising Phase 2 Clinical Trial Results for Ozuriftamab Vedotin in Treating Heavily Pretreated Squamous Cell Carcinoma of the Head and Neck at ESMO 2024BioAtla, a leading innovator in the realm of biopharmaceutical research, has unveiled compelling data from a Phase 2 clinical trial of its pio...
|
|
|
Company News
 Clinical Study
September 17, 2024
|
Company News
 Announcement
September 17, 2024
|
Company News
 Announcement
September 17, 2024
|
More Company News
|
Partnership
September 17, 2024
|
Product Service News
September 17, 2024
|
Product Service News
September 17, 2024
|
Product Service News
September 17, 2024
|
Product Service News
September 17, 2024
|
Product Service News
September 17, 2024
|
Clinical Study
September 17, 2024
|
Product Service News
September 17, 2024
|
Business Update
September 17, 2024
|
Business Update
September 17, 2024
|
|
|
|
Related News
|
Business Update
|
Clinical Study
|
|
Stocks
|
Product Service News
|
Product Service News
|
Partnership
|
|
|
|
Business News
|
 Management Changes
Understanding Brown & Brown, Inc. s Recent Leadership Changes and Market Performance: A Dive into Financial Updates and Cultural Influences
On September 16, 2024, Brown & Brown, Inc. (NYSE: BRO), a prominent player in the insurance industry, announced a significant shift in its senior leadership team with the ap...
|
|
Product Service News
Revolutionizing Mental Health Care: NeuroStar s Commitment to Patient-Centric Solutions In a groundbreaking advancement for mental health care, NeuroStar, a leader in transcranial magnetic stimulation (TMS) therapy, has recently announced a suite of software upgrades designed to enhance patient care across multiple ...
|
 Contract
REE Automotive Embarks on Global Manufacturing Endeavor with Esteemed Motherson Group: A Strategic Convergence to Accelerate Scalability In this era of unprecedented technological advancement and industrial ingenuity, it is with considerable delight that we relay the recent momentous development of REE Automotive, a...
|
 Clinical Study
A Memorable : In the venerable annals of medical inquiry, under the resplendent aegis of modern innovation, our esteemed colleagues at Merit Medical have ushered forth a prodigious advancement hitherto unseen in the annals of vascular intervention. The recent WRAPSODY WAVE Trial has unfurled a tapestry of hope for ...
|
 Product Service News
In the present age of rapid technological advancement, wherein clandestine endeavors are adeptly masked beneath layers of digital obfuscation, it becomes paramount for the guardians of law and order to possess the most sophisticated tools at their disposal. In an illustrious development that bespeaks the continuing ...
|
Our Most Popular Articles
|
 Announcement
In the fast-paced world of biotechnology, the importance of protecting investor interests cannot be overstated. As the landscape shifts with breakthrough research and corporate developments, the cautionary tales of missteps and missed opportunities proliferate. In this regard, Rosen Law Firm, a respected global inve...
|
 Product Service News
Shining Through: Gatos Silver’s Stellar Q3 and Optimistic 2024 Outlook In the dynamic realm of the precious metals industry, Gatos Silver, Inc. a prominent figure in silver mining, recently unveiled their production results for the third quarter of 2024. In a world where economic fluctuations are constant and mark...
|
 Product Service News
Utrecht, The Netherlands, and Cambridge, Mass. - Merus N.V. (Nasdaq: MRUS), a leading clinical-stage oncology company specializing in the development of innovative antibodies for cancer treatment, is thrilled to announce today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designat...
|
More News
|
 Clinical Study
Forging New Frontiers in Cancer Therapy: NextCure Unveils Promising Phase 1b Study Results at ESMO 2024 BELTSVILLE, Md. Sept. 16, 2024 In a stirring presentation, NextCure, Inc. (Nasdaq: NXTC) revealed groundbreaking clinical data at the European Society for Medical Oncology (ESMO) 2024 Congress. This clinical-s...
|
 Clinical Study
In this esteemed publication, we take the liberty of presenting findings that emanated from a notable assembly, the European Society for Medical Oncology (ESMO) Congress of the year 2024, where Apollomics revealed significant data concerning Vebreltinib a novel therapeutic agent under examination for its utility i...
|
 Clinical Study
BioAtla Demonstrates Promising Phase 2 Clinical Trial Results for Ozuriftamab Vedotin in Treating Heavily Pretreated Squamous Cell Carcinoma of the Head and Neck at ESMO 2024BioAtla, a leading innovator in the realm of biopharmaceutical research, has unveiled compelling data from a Phase 2 clinical trial of its pio...
|
 Clinical Study
Actuate Therapeutics Unveils New Insights into Combating One of the Most Aggressive Cancers At the AACR Special Conference on Advances in Pancreatic Cancer Research, Actuate Therapeutics, Inc. revealed preliminary findings from a Phase 2 trial exploring the use of elraglusib and losartan in conjunction with the ...
|
 Announcement
In the grand tapestry of medical science, wherein every thread constitutes the ceaseless pursuit of knowledge and advancement, recent pronouncements from Allarity Therapeutics render a noteworthy addition. The firm hath disclosed that two esteemed patients, subjects of a noble trial employing Stenoparib, have transc...
|
 Announcement
DO Apparel Partners with Kornit Digital to Enhance Custom Jersey Production Despite Financial Setback By Published on Today s DateROSH HA`AYIN, Israel In an effort to revolutionize the production of custom sports apparel, DO Apparel has expanded its collaboration with Kornit Digital LTD. (NASDAQ: KRNT), a global...
|
 Partnership
In a recent announcement, Korro Bio has forged a strategic partnership with pharmaceutical giant Novo Nordisk, focusing on the development of two therapeutic candidates aimed at addressing cardiometabolic diseases. This collaboration is set to leverage Korro Bio s proprietary OPERAâ„¢ platform, which specializes in ...
|
 Product Service News
Yoshitsu Co. Ltd Expands Reiwatakiya Brand in Hong Kong, Plans Broader Expansion Across Asia In a most ardent pursuit to capture the hearts and wallets of discerning customers, Yoshitsu Co. Ltd, an illustrious purveyor of Japanese beauty and health products, sundry goods, luxury items, and electronic marvels, has he...
|
 Product Service News
In the rapidly evolving landscape of medical technology, events that facilitate knowledge exchange and collaborative learning are more critical than ever. Recently, Profound Medical hosted its much-anticipated PRO-Talk Live! event, a remarkable gathering that shone a spotlight on the present and future of TULSA a gr...
|
 Product Service News
In a significant milestone for the decentralized clinical trials (DCT) landscape, Science 37 has been awarded the 2024 Global Company of the Year Award by Frost & Sullivan. This honor not only underscores Science 37’s position as an industry leader but also highlights the growing importance of decentralized method...
|
 Product Service News
In an age where supply chain resilience and efficiency are more critical than ever, BOS Better Online Solutions Ltd. (BOS) is making strategic moves that signal both growth prospects and geographical expansion. Recently, the company’s Supply Chain Division has not only secured a substantial order from the aerospac...
|
 Product Service News
Title : Lotus Robotics Seals Partnership with Japanese Tier-One Supplier, Eyes Market ExpansionIn a significant development for Lotus Technology Inc. (Lotus Tech), the company s intelligent driving division, Lotus Robotics, has been selected to supply cutting-edge technology to a renowned Japanese tier-one automotiv...
|
 Clinical Study
In a significant development for the pharmaceutical landscape, BioVie, a clinical-stage company focused on advancing innovative therapies, has recently announced the successful acquisition of all necessary scientific approvals requisite for the large-scale financing of its pivotal Phase 2 clinical trial for Bezisterim. This trial aims to investigate the efficacy of Bezisterim in treating Long COVID, a condition characterized by lingering symptoms that affect a significant portion of patients recovering from COVID-19.The critical green light came from the U.S. Army Medical Research and Development Command’s Office of Human Research Oversight, representing the final scientific milestone for BioVie to secure approximately $12.6 million in grant funding, part of a larger $13.1 million package. This funding is not only essential for the operational aspects of conducting the trial but also reflects confidence from governmental health bodies in BioVie’s approach to tackling Long COVID, an area of increasing concern in public health.
|
|
Product Service News
InnovAge Holding Corp (NASDAQ: INNV), a prominent provider of Programs of All-Inclusive Care for the Elderly (PACE), has recently been selected to participate in a national study aimed at preventing falls among seniors. This initiative aligns with the company s commitment to enhancing the quality of life for older a...
|
 Business Update
Modivcare Provides Financial Update: A Panoramic View on Receivables and Resilience In an era where healthcare services are increasingly pivoting towards technology-enabled solutions, Modivcare Inc. (Nasdaq: MODV) continues to make waves as a pioneering force in the industry. Headquartered in Denver, Modivcare is on...
|
 Business Update
In a significant development for the electric vehicle (EV) supply chain, Piedmont Lithium has received an environmental permit from Ghana’s Environmental Protection Agency (EPA) for the Ewoyaa Lithium Project. This project represents a crucial venture for Piedmont, which aims to become a leading North American sup...
|
|
|
|
|
